Literature DB >> 34459963

[Systemic lupus erythematosus induced by tumor necrosis fractor inhibitor-A rare side effect of intermediate uveitis treatment].

Janine Lenk1, Egbert Matthé2, Lutz E Pillunat2, Martin Aringer3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34459963     DOI： 10.1007/s00347-021-01481-7

Source DB:  PubMed          Journal:  Ophthalmologie        ISSN： 2731-720X


× No keyword cloud information.
  2 in total

1.  Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.

Authors:  Eric B Suhler; Glenn J Jaffe; Eric Fortin; Lyndell L Lim; Pauline T Merrill; Andrew D Dick; Antoine P Brezin; Quan Dong Nguyen; Jennifer E Thorne; Joachim Van Calster; Luca Cimino; Alfredo Adan; Hiroshi Goto; Toshikatsu Kaburaki; Michal Kramer; Albert T Vitale; Martina Kron; Alexandra P Song; Jianzhong Liu; Sophia Pathai; Kevin M Douglas; Ariel Schlaen; Cristina Muccioli; Mirjam E J Van Velthoven; Manfred Zierhut; James T Rosenbaum
Journal:  Ophthalmology       Date:  2020-11-03       Impact factor: 12.079

2.  Polyautoimmunity in systemic lupus erythematosus: secondary Sjogren syndrome.

Authors:  Cristiana Sieiro Santos; Clara Moriano Morales; Carolina Álvarez Castro; Elvira Díez Alvarez
Journal:  Z Rheumatol       Date:  2021-07-21       Impact factor: 1.372
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.